Investors are looking past short-term compliance issues, betting on the company’s strong balance sheet and eventual policy normalization in China. While the road ahead isn’t smooth, the current price may reflect more pessimism than reality; making it a candidate for contrarian plays. Keep an eye on regulatory clarity and capital allocation decisions in the coming quarters; they could be the catalysts that turn sentiment around. Not for the faint-hearted, but for those who understand value investing in emerging markets, Lufax might be worth a closer look.